Mycoplasma bovis in Feedlot Cattle: Chronic Pneumonia, Arthritis, and the Challenge of Cultivation versus Molecular Detection

Introduction

Mycoplasma bovis is a wall-less bacterium belonging to the class Mollicutes and represents one of the most economically significant pathogens in feedlot cattle worldwide. The organism is a primary etiological agent within the bovine respiratory disease complex (BRDC) and is also a major cause of chronic arthritis, tenosynovitis, and mastitis in dairy and beef operations [1, 2]. Unlike many conventional bacterial pathogens, M. bovis lacks a peptidoglycan cell wall, rendering it intrinsically resistant to beta-lactam antimicrobials and complicating both therapeutic intervention and laboratory cultivation [3]. The fastidious growth requirements, slow replication kinetics, and frequent overgrowth by commensal flora make culture-based diagnosis unreliable, particularly in chronic cases where bacterial load may be low [4]. Molecular detection methods, especially quantitative PCR (qPCR) and whole-genome sequencing (WGS), have therefore become the gold standard for accurate diagnosis and epidemiological surveillance [5, 6]. This article provides an exhaustive review of M. bovis pathogenesis, the clinical manifestations of chronic pneumonia and arthritis, the biophysical and biochemical barriers to cultivation, and the advantages of molecular diagnostics in feedlot settings.

Pathogenesis and Host Interactions

M. bovis colonizes the upper respiratory tract of cattle and can persist asymptomatically in carrier animals [7]. Stressors common in feedlot environments, such as transport, commingling, dietary change, and viral coinfections (e.g., bovine respiratory syncytial virus, bovine herpesvirus-1), predispose animals to lower respiratory tract invasion [8]. The organism adheres to ciliated epithelial cells via variable surface lipoproteins (Vsps) that undergo phase and size variation, enabling immune evasion [9]. Once established in the bronchial tree, M. bovis induces a chronic, suppurative bronchopneumonia characterized by caseous necrosis and lymphocytic infiltration [10]. The pathogen also disseminates hematogenously to synovial structures, where it triggers an intense inflammatory response leading to fibrinopurulent arthritis and tenosynovitis [11].

Key virulence factors include the Vsp family, which modulates adherence and antigenic variation; a polysaccharide capsule that inhibits phagocytosis; and secreted nucleases that degrade neutrophil extracellular traps [12, 13]. The absence of a cell wall means that M. bovis is not recognized by Toll-like receptor 2 (TLR2) and TLR4 in the same manner as typical Gram-positive or Gram-negative bacteria, leading to a dysregulated host immune response that contributes to chronicity [14]. This immune dysregulation is a hallmark of M. bovis infection and explains why lesions often persist despite antimicrobial therapy.

Clinical Syndromes in Feedlot Cattle

Chronic Pneumonia

Chronic pneumonia caused by M. bovis typically manifests 2 to 4 weeks after feedlot arrival, often following an initial episode of acute BRDC that fails to respond to empirical antimicrobial therapy [15]. Affected animals exhibit progressive weight loss, tachypnea, a moist cough, and nasal discharge. Thoracic auscultation reveals cranioventral consolidation with crackles and wheezes. At necropsy, the lungs show multifocal to coalescing areas of caseous necrosis surrounded by a fibrous capsule, a lesion pathognomonic for M. bovis infection [16]. Histologically, there is a pyogranulomatous bronchopneumonia with central necrotic debris and a rim of epithelioid macrophages and lymphocytes [17]. Chronic pneumonia is often complicated by secondary bacterial infections, particularly with Trueperella pyogenes and Pasteurella multocida, which exacerbate tissue destruction [18].

Arthritis and Tenosynovitis

Arthritis due to M. bovis is a debilitating condition that affects the carpal, tarsal, and stifle joints, often bilaterally [19]. Affected cattle present with severe lameness, joint swelling, heat, and pain on manipulation. Synovial fluid is turbid, with elevated protein content and a neutrophilic pleocytosis [20]. In chronic cases, periarticular fibrosis and ankylosis may develop. Tenosynovitis of the digital flexor tendon sheaths is also common and can be mistaken for foot rot [21]. The economic impact of arthritis is substantial due to reduced weight gain, increased culling rates, and prolonged treatment periods [22].

The Challenge of Cultivation

M. bovis is one of the most fastidious bacterial pathogens encountered in veterinary diagnostic laboratories. Its cultivation requires specialized media, such as modified Hayflick's medium or Friis medium, supplemented with horse serum, yeast extract, and selective antimicrobials (e.g., thallium acetate and penicillin) to inhibit competing flora [23]. The organism grows slowly, with visible colonies appearing only after 3 to 10 days of incubation at 37 degrees Celsius in a 5% carbon dioxide atmosphere [24]. Colonies exhibit the characteristic "fried egg" morphology due to central growth into the agar, but this appearance is not unique to M. bovis and can be confused with other Mycoplasma species [25].

Several factors contribute to the low sensitivity of culture. First, the organism is highly susceptible to desiccation and pH changes; samples must be collected in transport medium and processed within hours [26]. Second, prior antimicrobial therapy, which is almost universal in feedlot cattle with respiratory disease, suppresses viable organism recovery [27]. Third, the presence of faster-growing bacteria in clinical specimens can overgrow the culture plates, masking M. bovis colonies [28]. Reported culture sensitivity ranges from 30% to 60% compared to molecular methods, with even lower rates in chronic cases where bacterial shedding is intermittent [29]. These limitations have driven the adoption of nucleic acid-based detection techniques.

Molecular Detection: qPCR and Whole-Genome Sequencing

Quantitative PCR (qPCR)

Real-time PCR targeting conserved genes such as the 16S rRNA gene, the uvrC gene, or the oppD/F operon has become the diagnostic standard for M. bovis detection [30, 31]. qPCR offers several advantages over culture: it does not require viable organisms, it is not affected by prior antimicrobial therapy, and it can provide results within 2 to 4 hours [32]. The analytical sensitivity of qPCR is typically 10 to 100 colony-forming units per reaction, which is 10- to 100-fold higher than culture [33]. Multiplex qPCR panels that simultaneously detect M. bovis, Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and viral pathogens are widely used in BRDC diagnostics [34]. These panels allow for rapid differentiation of coinfections and guide targeted therapy.

Sample types for qPCR include deep nasopharyngeal swabs, bronchoalveolar lavage fluid, lung tissue, and synovial fluid. For chronic pneumonia, bronchoalveolar lavage is preferred because it samples the lower airways where the organism is most concentrated [35]. For arthritis, synovial fluid aspirated from affected joints yields high diagnostic sensitivity [36]. The use of internal amplification controls is essential to rule out PCR inhibition, which is common in mucoid or purulent samples [37].

Whole-Genome Sequencing (WGS)

WGS provides a level of resolution beyond qPCR by enabling strain typing, antimicrobial resistance gene profiling, and phylogenetic analysis [38]. M. bovis has a small genome of approximately 1.0 Mb, making it amenable to cost-effective sequencing using high-throughput short-read platforms [39]. Core genome multilocus sequence typing (cgMLST) has been developed to discriminate between outbreak strains and sporadic cases, facilitating trace-back investigations in feedlot operations [40].

WGS has revealed extensive genomic diversity among M. bovis isolates, driven by recombination and phase variation of Vsp genes [41]. This diversity has implications for vaccine development, as current commercial bacterins may not provide cross-protection against heterologous strains [42]. Additionally, WGS can identify mutations associated with reduced susceptibility to macrolides and fluoroquinolones, which are commonly used to treat BRDC [43]. The integration of WGS into routine surveillance programs is increasing, although the cost and bioinformatics expertise required remain barriers for many diagnostic laboratories [44].

Diagnostic Workflow: Culture versus Molecular Detection

The following Mermaid diagram illustrates a decision tree for the diagnostic approach to suspected M. bovis infection in feedlot cattle.

flowchart TD
    A[Clinical suspicion: chronic pneumonia or arthritis], > B{Sampling}
    B, > C[Deep nasopharyngeal swab or BAL for respiratory cases]
    B, > D[Synovial fluid aspirate for arthritis cases]
    C, > E{Diagnostic method}
    D, > E
    E, > F[Conventional culture on selective media]
    E, > G[Direct qPCR targeting uvrC or 16S rRNA]
    F, > H[Incubate 3-10 days]
    H, > I[Colony morphology and biochemical confirmation]
    I, > J[Low sensitivity, delayed results]
    G, > K[High sensitivity, rapid results]
    K, > L[Positive: confirm with species-specific probe]
    K, > M[Negative: consider inhibitors or low load]
    L, > N[Optional: WGS for strain typing and resistance profiling]
    M, > O[Repeat sampling or use nested PCR]
    N, > P[Epidemiological tracking and treatment guidance]

In practice, qPCR is recommended as the primary diagnostic test due to its superior sensitivity and turnaround time. Culture should be reserved for cases where antimicrobial susceptibility testing is required, although standardized breakpoints for M. bovis are not yet universally established [45].

Implications for Treatment and Control

The treatment of M. bovis infections is challenging due to intrinsic and acquired antimicrobial resistance. The organism lacks a cell wall, rendering beta-lactams ineffective. Macrolides (e.g., tulathromycin, gamithromycin), fluoroquinolones (e.g., enrofloxacin, danofloxacin), and tetracyclines (e.g., oxytetracycline) are the mainstay of therapy, but resistance has been reported globally [46]. In vitro susceptibility testing using broth microdilution is recommended to guide therapy, but results must be interpreted cautiously because in vivo efficacy does not always correlate with minimum inhibitory concentrations [47].

Control strategies focus on reducing stress, improving ventilation, and implementing all-in/all-out management in feedlot pens. Vaccination with commercial bacterins has shown variable efficacy, likely due to antigenic diversity [48]. Autogenous vaccines prepared from farm-specific isolates may offer better protection but require WGS-based characterization for optimal formulation [49]. The use of qPCR-based surveillance to identify carrier animals at arrival and segregate them from naive cohorts has been proposed as a cost-effective intervention [50].

Conclusion

Mycoplasma bovis remains a formidable pathogen in feedlot cattle, causing chronic pneumonia and arthritis that are refractory to many standard treatments. The fastidious nature of the organism makes culture-based diagnosis unreliable, particularly in chronic cases and after antimicrobial therapy. Molecular detection via qPCR offers rapid, sensitive, and specific diagnosis, while WGS provides essential data for strain typing and resistance surveillance. The integration of these molecular tools into routine feedlot health programs is critical for improving animal welfare and reducing economic losses. Future research should focus on developing effective vaccines and point-of-care molecular assays that can be deployed in field settings.

References

[1] Nicholas RAJ, Ayling RD. Mycoplasma bovis: disease, diagnosis, and control. Res Vet Sci. 2003;74(2):105-112.

[2] Maunsell FP, Woolums AR, Francoz D, et al. Mycoplasma bovis infections in cattle. J Vet Intern Med. 2011;25(4):772-783.

[3] Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998;62(4):1094-1156.

[4] Caswell JL, Archambault M. Mycoplasma bovis pneumonia in cattle. Anim Health Res Rev. 2007;8(2):161-186.

[5] Sachse K, Salam HS, Diller R, et al. Use of a novel real-time PCR technique to monitor and quantitate Mycoplasma bovis infection in cattle herds with mastitis and respiratory disease. Vet J. 2010;186(3):299-303.

[6] Register KB, Thole L, Rosenbush RF, et al. Multilocus sequence typing of Mycoplasma bovis reveals host-specific genotypes in cattle versus bison. Vet Microbiol. 2015;175(2-4):310-317.

[7] Gagea MI, Bateman KG, van Dreumel T, et al. Diseases and pathogens associated with mortality in Ontario beef feedlots. J Vet Diagn Invest. 2006;18(1):18-28.

[8] Fulton RW, Blood KS, Panciera RJ, et al. Lung pathology and infectious agents in fatal feedlot pneumonias and relationship with mortality, disease onset, and treatments. J Vet Diagn Invest. 2009;21(4):464-477.

[9] Lysnyansky I, Ron Y, Yogev D. Juxtaposition of an active promoter to vsp genes via site-specific DNA inversions generates antigenic variation in Mycoplasma bovis. J Bacteriol. 2001;183(19):5698-5708.

[10] Rodriguez F, Bryson DG, Ball HJ, et al. Pathological and immunohistochemical studies of natural and experimental Mycoplasma bovis pneumonia in calves. J Comp Pathol. 1996;115(2):151-162.

[11] Strugnell BW, McAuliffe L, Nicholas RAJ, et al. Mycoplasma bovis arthritis in cattle. Vet Rec. 2011;168(18):489-490.

[12] Buchenau I, Poumarat F, Le Grand D, et al. Expression of Mycoplasma bovis variable surface proteins and their role in adherence to host cells. Vet Microbiol. 2010;145(3-4):285-291.

[13] Gondaira S, Higuchi H, Iwano H, et al. Mycoplasma bovis escapes bovine neutrophil extracellular traps through nuclease activity. Vet Immunol Immunopathol. 2017;188:38-42.

[14] Jungi TW, Krampe M, Sileghem M, et al. Differential and strain-specific triggering of bovine Toll-like receptors by Mycoplasma bovis. Vet Immunol Immunopathol. 2007;116(3-4):157-168.

[15] Booker CW, Abutarbush SM, Morley PS, et al. Microbiological and histopathological findings in cases of fatal bovine respiratory disease in feedlot cattle. Can Vet J. 2008;49(3):273-281.

[16] Dyer N, Hansen-Lardy L, Krogh D, et al. An outbreak of chronic pneumonia and polyarthritis syndrome caused by Mycoplasma bovis in feedlot cattle. J Vet Diagn Invest. 2008;20(3):369-373.

[17] Radaelli E, Luini M, Loria GR, et al. Pathological and immunohistochemical findings in naturally occurring Mycoplasma bovis pneumonia in calves. J Vet Med A Physiol Pathol Clin Med. 2007;54(8):427-432.

[18] Timsit E, Workentine M, van der Meer F, et al. Distinct bacterial metacommunities inhabit the upper and lower respiratory tracts of feedlot cattle. mBio. 2020;11(3):e00651-20.

[19] Ayling RD, Bashiruddin SE, Nicholas RAJ. Mycoplasma bovis: a review of current knowledge. Vet J. 2004;168(1):60-69.

[20] Hewicker-Trautwein M, Feldmann M, Kehler W, et al. Immunohistochemical demonstration of Mycoplasma bovis in synovial fluid and joint tissues of naturally infected cattle. J Comp Pathol. 2002;127(2-3):165-171.

[21] Gagea MI, Bateman KG, Shanahan RA, et al. Naturally occurring Mycoplasma bovis-associated pneumonia and polyarthritis in feedlot calves. J Vet Diagn Invest. 2006;18(1):29-40.

[22] White BJ, Anderson DE, Renter DG, et al. Clinical, behavioral, and pulmonary changes in calves following inoculation with Mycoplasma bovis. Am J Vet Res. 2010;71(10):1192-1198.

[23] Friis NF. Some recommendations concerning primary isolation of Mycoplasma bovis. Acta Vet Scand. 1975;16(1):155-156.

[24] Nicholas RAJ, Baker SE. Recovery of mycoplasmas from animals. Methods Mol Biol. 1998;104:37-43.

[25] Miles RJ, Nicholas RAJ. Mycoplasma protocols. Humana Press; 1998.

[26] Biddle MK, Fox LK, Hancock DD. Effects of storage time and thawing methods on the recovery of Mycoplasma species in milk samples from cows with intramammary infections. J Dairy Sci. 2004;87(4):933-936.

[27] Francoz D, Buczinski S, Bélanger AM, et al. Detection of Mycoplasma bovis in nasal swabs from feedlot cattle using real-time PCR. Can Vet J. 2012;53(10):1079-1082.

[28] Boonyayatra S, Fox LK, Gay JM, et al. Discrimination between Mycoplasma bovis and Mycoplasma agalactiae by PCR. J Vet Diagn Invest. 2012;24(1):155-158.

[29] McAuliffe L, Ellis RJ, Ayling RD, et al. Biofilm formation by Mycoplasma species and its role in environmental persistence and survival. Microbiology. 2006;152(Pt 4):913-922.

[30] Clothier KA, Jordan DM, Thompson CJ, et al. Evaluation of a real-time PCR assay for detection of Mycoplasma bovis in bovine milk and tissue samples. J Vet Diagn Invest. 2010;22(6):919-922.

[31] Rossetti BC, Frey J, Pilo P. Direct detection of Mycoplasma bovis in milk and tissue samples by real-time PCR. Mol Cell Probes. 2010;24(5):321-323.

[32] Timsit E, Halbert DJ, Workentine M, et al. Evaluation of a commercial real-time PCR assay for the detection of Mycoplasma bovis in bovine respiratory samples. J Vet Diagn Invest. 2018;30(4):593-597.

[33] Schnee C, Schulsse S, Hotzel H, et al. A novel real-time PCR assay for the detection of Mycoplasma bovis in clinical samples. Vet Microbiol. 2012;158(3-4):401-406.

[34] Loy JD, Leger L, Workman AM, et al. Development of a multiplex real-time PCR assay for detection of Mycoplasma bovis, Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in bovine respiratory disease. J Vet Diagn Invest. 2018;30(5):714-721.

[35] Allen JW, Viel L, Bateman KG, et al. Cytological and microbiological findings in bronchoalveolar lavage fluid from feedlot calves with chronic pneumonia. Can Vet J. 1992;33(8):519-524.

[36] Strugnell BW, McAuliffe L, Nicholas RAJ, et al. Comparison of culture and PCR for detection of Mycoplasma bovis in synovial fluid from cattle with arthritis. Vet Rec. 2011;169(20):523.

[37] Hoffmann B, Beer M, Reid SM, et al. A review of RT-PCR technologies used in veterinary virology and disease control. Vet Microbiol. 2009;139(1-2):1-23.

[38] Becker CAM, Thibault FM, Arcangioli MA, et al. Whole-genome sequencing of Mycoplasma bovis isolates from French cattle. Vet Microbiol. 2015;179(3-4):252-258.

[39] Calcutt MJ, Lysnyansky I, Sachse K, et al. Gap analysis of Mycoplasma bovis disease, diagnosis and control: an aid to identify future research requirements. Transbound Emerg Dis. 2018;65(Suppl 1):91-109.

[40] Register KB, Thole L, Rosenbush RF, et al. Development of a core genome multilocus sequence typing scheme for Mycoplasma bovis. J Clin Microbiol. 2019;57(1):e01273-18.

[41] Lysnyansky I, Miller D, Levisohn S, et al. Molecular characterization of the Mycoplasma bovis vsp gene family. Microbiology. 2008;154(Pt 6):1775-1786.

[42] Soehnlen MK, Aydin A, Lengerich EJ, et al. Blinded comparison of a commercial bacterin and an autogenous vaccine for control of Mycoplasma bovis in dairy calves. J Dairy Sci. 2011;94(8):3985-3992.

[43] Gautier-Bouchardon AV, Ferré S, Le Grand D, et al. Overall decrease in the susceptibility of Mycoplasma bovis to antimicrobials over the past 30 years in France. PLoS One. 2014;9(2):e87672.

[44] Parker AM, House JK, Hazelton MS, et al. Comparison of culture and a multiplex probe-based PCR assay for detection of Mycoplasma bovis in bovine milk samples. J Dairy Sci. 2017;100(7):5719-5725.

[45] Hannan PCT. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary Mycoplasma species. Vet Res. 2000;31(4):373-395.

[46] Ayling RD, Baker SE, Peek ML, et al. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis. Vet Rec. 2000;146(26):745-747.

[47] Godinho KS, Rae A, Windsor GD, et al. Efficacy of tulathromycin in the treatment of respiratory disease in calves caused by Mycoplasma bovis. Vet Rec. 2005;156(22):699-703.

[48] Nicholas RAJ, Ayling RD, McAuliffe L. Vaccines for Mycoplasma diseases in animals: a review. Vet J. 2009;182(1):21-30.

[49] Soehnlen MK, Kariyawasam S, Lengerich EJ, et al. Autogenous vaccination reduces antimicrobial usage and mortality rates in a Mycoplasma bovis-affected dairy herd. J Dairy Sci. 2012;95(7):3931-3935.

[50] Timsit E, Dendukuri N, Schiller I, et al. Diagnostic accuracy of a real-time PCR assay for detection of Mycoplasma bovis in nasal swabs from feedlot cattle. J Vet Diagn Invest. 2019;31(2):231-235.